Opportunistic Infections Citation List:
January 4 - January 17, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Proangiogenic Growth Factors Potentiate in Situ Angiogenesis and Enhance Antifungal Drug Activity in Murine Invasive Aspergillosis. Ben-Ami, R., N.D. Albert, R.E. Lewis, and D.P. Kontoyiannis. The Journal of Infectious Diseases, 2013. [Epub ahead of print]. PMID[23303813].

[PubMed]. OI_0104-011713.

2. Antifungal Activity of Azole Compounds CPA18 and CPA109 against Azole-susceptible and -resistant Strains of Candida albicans. Calabrese, E.C., S. Castellano, M. Santoriello, C. Sgherri, M.F. Quartacci, L. Calucci, A.G. Warrilow, D.C. Lamb, S.L. Kelly, C. Milite, I. Granata, G. Sbardella, G. Stefancich, B. Maresca, and A. Porta. The Journal of Antimicrobial Chemotherapy, 2013. [Epub ahead of print]. PMID[23292344].

[PubMed]. OI_0104-011713.

3. Synthesis, Structure-Activity Relationships (SAR) and in Silico Studies of Coumarin Derivatives with Antifungal Activity. de Araujo, R.S., F.Q. Guerra, O.L.E. de, C.A. de Simone, J.F. Tavares, L. Scotti, M.T. Scotti, T.M. de Aquino, R.O. de Moura, F.J. Mendonca, and J.M. Barbosa-Filho. International Journal of Molecular Sciences, 2013. 14(1): p. 1293-1309. PMID[23306152].

[PubMed]. OI_0104-011713.

4. Evaluation of the Anticryptococcal Activity of the Antibiotic Polymyxin B in Vitro and in Vivo. Zhai, B. and X. Lin. International Journal of Antimicrobial Agents, 2013. [Epub ahead of print].PMID[23313397].

[PubMed]. OI_0104-011713.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

5. Current Prospects of Synthetic Curcumin Analogues and Chalcone Derivatives against Mycobacterium tuberculosis. Abbas Bukhari, S.N., S.G. Franzblau, I. Jantan, and M. Jasamai. Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23305394].
[PubMed]. OI_0104-011713.

6. Fueling Open-source Drug Discovery: 177 Small-molecule Leads against Tuberculosis. Ballell, L., R.H. Bates, R.J. Young, D. Alvarez-Gomez, E. Alvarez-Ruiz, V. Barroso, D. Blanco, B. Crespo, J. Escribano, R. Gonzalez, S. Lozano, S. Huss, A. Santos-Villarejo, J.J. Martin-Plaza, A. Mendoza, M.J. Rebollo-Lopez, M. Remuinan-Blanco, J.L. Lavandera, E. Perez-Herran, F.J. Gamo-Benito, J.F. Garcia-Bustos, D. Barros, J.P. Castro, and N. Cammack. ChemMedChem, 2013. [Epub ahead of print]. PMID[23307663].
[PubMed]. OI_0104-011713.

7. Synthesis, Antitubercular Activity and Mechanism of Resistance of Highly Effective Thiacetazone Analogues. Coxon, G.D., D. Craig, R.M. Corrales, E. Vialla, L. Gannoun-Zaki, and L. Kremer. PloS One, 2013. 8(1): p. e53162. PMID[23301038].
[PubMed]. OI_0104-011713.

8. Production of 3-Nitropropionic acid by Endophytic Fungus Phomopsis longicolla Isolated from Trichilia elegans A. JUSS ssp. elegans and Evaluation of Biological Activity. Flores, A.C., J.A. Pamphile, M.H. Sarragiotto, and E. Clemente. World Journal of Microbiology & Biotechnology, 2013. [Epub ahead of print]. PMID[23296917].
[PubMed]. OI_0104-011713.

9. Discovery and Evaluation of Novel Inhibitors of Mycobacterium Protein Tyrosine Phosphatase B from the 6-Hydroxy-benzofuran-5-carboxylic acid Scaffold. He, Y., J. Xu, Z.H. Yu, A. Gunawan, L.L. Wu, L. Wang, and Z.Y. Zhang. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23305444].
[PubMed]. OI_0104-011713.

10. Synergistic Activities of Tigecycline with Clarithromycin or Amikacin against Rapidly Growing Mycobacteria in Taiwan. Huang, C.W., J.H. Chen, S.T. Hu, W.C. Huang, Y.C. Lee, C.C. Huang, and G.H. Shen. International Journal of Antimicrobial Agents, 2013. [Epub ahead of print]. PMID[23312605].
[PubMed]. OI_0104-011713.

11. Thiolactomycin-based β-Ketoacyl-AcpM Synthase A (KasA) Inhibitors: Fragment-based Inhibitor Discovery Using Transient 1D NOE NMR Spectroscopy. Kapilashrami, K., G.R. Bommineni, C.A. Machutta, P. Kim, C.T. Lai, C. Simmerling, F. Picart, and P.J. Tonge. The Journal of Biological Chemistry, 2013. [Epub ahead of print]. PMID[23306195].
[PubMed]. OI_0104-011713.

12. Modification of Proportion Sensitivity Testing Method for Ethionamide. Lakshmi, R., R. Ramachandran, K. Devika, G. Radhika, A. Syam Sundar, F. Rahman, N. Selvakumar, and V. Kumar. World Journal of Microbiology & Biotechnology, 2013. [Epub ahead of print]. PMID[23315266].
[PubMed]. OI_0104-011713.

13. Antitubercular Activity and Subacute Toxicity of (-)-Licarin A in BALB/c Mice: A Neolignan Isolated from Aristolochia taliscana. Leon-Diaz, R., M. Meckes-Fischer, L. Valdovinos-Martinez, H.R. Hernandez-Pando, M.G. Campos, and M.A. Jimenez-Arellanes. Archives of Medical Research, 2013. [Epub ahead of print]. PMID[23291382].
[PubMed]. OI_0104-011713.

14. Activity of Drug Combinations against Mycobacterium tuberculosis Grown in Aerobic and Hypoxic Acidic Conditions. Piccaro, G., F. Giannoni, P. Filippini, A. Mustazzolu, and L. Fattorini. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23295931].
[PubMed]. OI_0104-011713.

15. Kinetic Mechanism and Inhibition of Mycobacterium tuberculosis D-Alanine:D-Alanine Ligase by the Antibiotic D-Cycloserine. Prosser, G.A. and L.P. de Carvalho. The FEBS Journal, 2013. [Epub ahead of print]. PMID[23286234].
[PubMed]. OI_0104-011713.

16. In Vitro Effect of Three-drug Combinations of Antituberculous Agents against Multidrug-resistant Mycobacterium tuberculosis Isolates. Rey-Jurado, E., G. Tudo, J.P. de la Bellacasa, M. Espasa, and J. Gonzalez-Martin. International Journal of Antimicrobial Agents, 2013. [Epub ahead of print]. PMID[23312604].
[PubMed]. OI_0104-011713.

17. Discovery of Novel Acetohydroxyacid Synthase Inhibitors as Active Agents against Mycobacterium tuberculosis by Virtual Screening and Bioassay. Wang, D., X. Zhu, C. Cui, M. Dong, H. Jiang, Z. Li, Z. Liu, W. Zhu, and J.G. Wang. Journal of Chemical Information and Modeling, 2013. [Epub ahead of print]. PMID[23316686].
[PubMed]. OI_0104-011713.

18. Synthesis and Antimycobacterial Evaluation of Pyrazinamide Derivatives with Benzylamino Substitution. Zitko, J., P. Paterova, V. Kubicek, J. Mandikova, F. Trejtnar, J. Kunes, and M. Dolezal. Bioorganic & Medicinal Chemistry Letters, 2013. 23(2): p. 476-479. PMID[23237840].
[PubMed]. OI_0104-011713.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

19. Synthesis of a Potent Antimalarial Agent through Natural Products Conjugation. Bruno, M., B. Trucchi, D. Monti, S. Romeo, M. Kaiser, and L. Verotta. ChemMedChem, 2013. [Epub ahead of print]. PMID[23307699].

[PubMed]. OI_0104-011713.

20. New bis-Thiazolium Analogues as Potential Antimalarial Agents: Design, Synthesis, and Biological Evaluation. Caldarelli, S.A., S. El Fangour, S. Wein, C. Tran van Ba, C. Perigaud, A. Pellet, H.J. Vial, and S. Peyrottes. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23289711].

[PubMed]. OI_0104-011713.

21. Discovery and Preliminary Structure-Activity Relationship Analysis of 1,14-Sperminediphenylacetamides as Potent and Selective Antimalarial Lead Compounds. Liew, L.P., M. Kaiser, and B.R. Copp. Bioorganic & Medicinal Chemistry Letters, 2013. 23(2): p. 452-454. PMID[23265884].

[PubMed]. OI_0104-011713.

22. Plasmodium falciparum Drug Resistance Phenotype as Assessed by Patient Antimalarial Drug Levels and Its Association with pfmdr1 Polymorphisms. Malmberg, M., P.E. Ferreira, J. Tarning, J. Ursing, B. Ngasala, A. Bjorkman, A. Martensson, and J.P. Gil. The Journal of Infectious Diseases, 2013. [Epub ahead of print].PMID[23225895].

[PubMed]. OI_0104-011713.

23. Antimalarial Pharmacology and Therapeutics of Atovaquone. Nixon, G.L., D.M. Moss, A.E. Shone, D.G. Lalloo, N. Fisher, P.M. O'Neill, S.A. Ward, and G.A. Biagini. The Journal of Antimicrobial Chemotherapy, 2013. [Epub ahead of print]. PMID[23292347].

[PubMed]. OI_0104-011713.

24. From a Cytotoxic Agent to the Discovery of a Novel Antimalarial Agent. Singh, R.S., U. Das, J.M. Auschwitz, S.E. Leed, M.R. Hickman, J.R. Dimmock, and J. Alcorn. Bioorganic & Medicinal Chemistry Letters, 2013. 23(2): p. 584-587. PMID[23228469].

[PubMed]. OI_0104-011713.

25. Antibacterial and Antiplasmodial Constituents of Beilschmiedia cryptocaryoides. Talontsi, F.M., M. Lamshoft, J.O. Bauer, A.A. Razakarivony, B. Andriamihaja, C. Strohmann, and M. Spiteller. Journal of Natural Products, 2013. [Epub ahead of print]. PMID[23320609].

[PubMed]. OI_0104-011713.

26. Alpha-heteroatom Derivatized Analogues of 3-(Acetylhydroxyamino)propyl phosphonic acid (FR900098) as Antimalarials. Verbrugghen, T., P. Vandurm, J. Pouyez, L. Maes, J. Wouters, and S. Van Calenbergh. Journal of Medicinal Chemistry, 2013. 56(1): p. 376-380. PMID[23215035].

[PubMed]. OI_0104-011713.

ANTIPROTOZOAL COMPOUNDS

27. All-trans Retinoic acid in Combination with Primaquine Clears Pneumocystis Infection. Lei, G.S., C. Zhang, S. Shao, H.W. Jung, P.J. Durant, and C.H. Lee. PloS One, 2013. 8(1): p. e53479. PMID[23308231].
[PubMed]. OI_0104-011713.

Citations from the ISI Web of Knowledge Listings for O.I.

28. The Added Effect of Thioridazine in the Treatment of Drug-resistant Tuberculosis. Amaral, L., Z. Udwadia, E. Abbate, and D. van Soolingen. International Journal of Tuberculosis and Lung Disease, 2012. 16(12): p. 1706-1708. ISI[000311588100026].
[WOS]. OI_0104-011713.

29. Synthesis and Antitubercular Evaluation of N-Arylpyrazine and N,N'-Alkyl-diylpyrazine-2-carboxamide Derivatives. Bispo, M.D.F., R.S.B. Goncalves, C.H.D. Lima, L.N.D. Cardoso, M.C.S. Lourenco, and M.V.N. de Souza. Journal of Heterocyclic Chemistry, 2012. 49(6): p. 1317-1322. ISI[000312298300006].
[WOS]. OI_0104-011713.

30. Computational Screening for New Inhibitors of M. tuberculosis Mycolyltransferases Antigen 85 Group of Proteins as Potential Drug Targets. Gahoi, S., R.S. Mandal, N. Ivanisenko, P. Shrivastava, S. Jain, A.K. Singh, M.V. Raghunandanan, S. Kanchan, B. Taneja, C. Mandal, V.A. Ivanisenko, A. Kumar, R. Kumar, S. Ramachandran, and Open Source Drug Discovery Consortium. Journal of Biomolecular Structure & Dynamics, 2013. 31(1): p. 30-43. ISI[000312447100004].
[WOS]. OI_0104-011713.

31. Azurophil Granule Proteins Constitute the Major Mycobactericidal Proteins in Human Neutrophils and Enhance the Killing of Mycobacteria in Macrophages. Jena, P., S. Mohanty, T. Mohanty, S. Kallert, M. Morgelin, T. Lindstrom, N. Borregaard, S. Stenger, A. Sonawane, and O.E. Sorensen. PloS One, 2012. 7(12) : p. e50345. ISI[000312386800012].

[WOS]. OI_0104-011713.

32. Synthesis and Antimicrobial Activity of 3-Aryl-4,5,6,7-tetrahydroindazoles. Pantyukhin, A.A., A.G. Mikhailovskii, G.A. Aleksandrova, R.R. Makhmudov, N.N. Pershina, and M.I. Vakhrin. Pharmaceutical Chemistry Journal, 2012. 46(8): p. 470-472. ISI[000312265800003].
[WOS]. OI_0104-011713.

33. Synthesis and Evaluation of Antimicrobial Activity of Some New Hetaryl-azoles Derivatives Obtained from 2-Aryl-4-methylthiazol-5-carbohydrazides and Isonicotinic acid hydrazide. Tiperciuc, B., V. Zaharia, I. Colosi, C. Moldovan, O. Crisan, A. Pirnau, L. Vlase, M. Duma, and O. Oniga. Journal of Heterocyclic Chemistry, 2012. 49(6): p. 1407-1414. ISI[000312298300020].

[WOS]. OI_0104-011713.

34. Influence of Substituent Effects on Spectroscopic Properties and Antimicrobial Activity of 5-(4'-Substituted phenylazo)-2-thioxothiazolidinone Derivatives. Abou-Dobara, M.I., A.Z. El-Sonbati, and S.M. Morgan. World Journal of Microbiology & Biotechnology, 2013. 29(1): p. 119-126. ISI[000312075300013].

[WOS]. OI_0104-011713.

35. Enhancement of Commercial Antifungal Agents by Kojic acid. Kim, J.H., P.K. Chang, K.L. Chan, N.C.G. Faria, N. Mahoney, Y.K. Kim, M.D. Martins, and B.C. Campbell. International Journal of Molecular Sciences, 2012. 13(11): p. 13867-13880. ISI[000311425000006].

[WOS]. OI_0104-011713.

36. Synthesis and in Vitro Antimycobacterial and Isocitrate Lyase Inhibition Properties of Novel 2-Methoxy-2 '-hydroxybenzanilides, Their Thioxo Analogues and Benzoxazoles. Kozic, J., E. Novotna, M. Volkova, J. Stolarikova, F. Trejtnar, V. Wsol, and J. Vinsova. European Journal of Medicinal Chemistry, 2012. 56: p. 108-119. ISI[000311873600010].

[WOS]. OI_0104-011713.

37. Microbial Transformation of Antimalarial Terpenoids. Parshikov, I.A., A.I. Netrusov, and J.B. Sutherland. Biotechnology Advances, 2012. 30(6): p. 1516-1523. ISI[000311859100028].

[WOS]. OI_0104-011713.